title: Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients.
authors.affiliation: Division of Gastroenterology, University of Missouri, Columbia, Missouri, USA. veyseltahan@yahoo.com
authors.forename: Alp Serhat
authors.initials: AS
authors.lastname: Kahveci
authors.forename: Veysel
authors.initials: V
authors.lastname: Tahan
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D002219:Carbamates / Q000494:pharmacology*; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006576:Heterocyclic Compounds, 4 or More Rings / Q000494:pharmacology*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000069474:Sofosbuvir / Q000494:pharmacology*; D001562:Benzimidazoles; D001578:Benzopyrans
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D006576:Heterocyclic Compounds, 4 or More Rings; D000069474:Sofosbuvir; C000604171:velpatasvir; D001562:Benzimidazoles; D001578:Benzopyrans